Human neuronal nicotinic receptors

Progress in Neurobiology

Volumn 53, Issue 2, 1997, Pages 199-237

  Gotti, C ^a,b   Fornasari, D ^a   Clementi, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; ANATOXIN A; BUNGAROTOXIN; CHLORISONDAMINE; CONOTOXIN; EPIBATIDINE; IBOGAINE; MECAMYLAMINE; NICOTINIC RECEPTOR; SEROTONIN; TUBOCURARINE CHLORIDE;

CELL LINE; CHOLINERGIC TRANSMISSION; HUMAN; LIGAND BINDING; MOLECULAR CLONING; NERVE CONDUCTION; OOCYTE; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; TRANSCRIPTION REGULATION;

HUMANS; NEURONS; RECEPTORS, NICOTINIC;

EID: 0030769188     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(97)00034-8     Document Type: Review

References (298)

1. 3H-acetylcholine receptor autoradiography. J. Neural Transm. 73, 77-83.
2. Adem, A., Nordberg, A., Jossan, S. S., Sara, V. and Gillberg, P.-G. (1989) Quantitative autoradiography of nicotinic receptors in large cryosections of human brain hemispheres. Neurosci. Lett. 101, 247-252.
3. Adler, L. E., Hoffer, L. J., Griffith, J., Waldo, M. C. and Freedman, R. (1992) Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol. Psychiat. 32, 607-616.
4. Akasu, T. and Koketsu, K. (1986) 5-Hydroxytryptamine decreases the sensitivity of nicotinic acetylcholine receptor in bull-frog sympathetic ganglion cells. J. Physiol. (Lond.) 380, 93-109.
5. Albuquerque, E. X., Pereira, E. F. R., Castro, N. G., Alkondon, M., Reinhardt, S., Schröder, H. and Maelicke, A. (1995) Nicotinic receptor function in the mammalian central nervous system. Ann. NY Acad. Sci. 757, 48-72.
6. Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., Schrattenholz, A. and Maelicke, A. (1997) Nicotinic acetylcholine receptors on hippocampal neurons: distribution on the neuronal surface and modulation of receptor activity. J. Res. Rec. 17, 243-266.
7. Alkondon, M., Rocha, E. S., Maelicke, A. and Albuquerque, E. X. (1996) Diversity of nicotinic acetylcholine receptors in rat brain. V. α-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. J. Pharmacol. Expl Ther. 278, 1460-1471.
8. American Cancer Society (1994) Cancer Facts and Figures - 1994. p. 5. American Cancer Society, Inc.: Atlanta, GA.
9. Anand, R. and Lindstrom, J. (1990) Nucleotide sequence of the human nicotinic acetylcholine receptor β2 subunit gene. Nucleic Acids Res. 18, 4272.
10. Anand, R., Conroy, W. G., Schoepfer, R., Whiting, P and Lindstrom, J. (1990) Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J. Biol. Chem. 266, 11192-11198.
11. Anand, R. and Lindstrom, J. (1992) Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. Genomics 13, 962-967.
12. Anand, R., Peng, X., Ballesta, J. J. and Lindstrom, J. (1993) Pharmacological characterization of α-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of α7 and α8 subunit-containing subtypes. Mol. Pharmacol. 44, 1046-1050.
13. Araujo, D. M., Lapchak, P. A., Robitaille, Y., Gauthier, S. and Quirion, R. (1988) Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J. Neurochem. 50, 1914-1923.
14. Arneric, S. P., Sullivan, J. P., Briggs, C. A., Donnelly-Roberts, D., Anderson, D. J., Raskiewicz, J. L., Hughes, M., Cadman, E., Adams, E. D., Garvey, D. S., Wasicak, J. and Williams, M. (1994) ABT 418: a novel cholinergic ligand with cognition enhancing and anxiolytic activity: 1. In vitro activity. J. Pharmacol. Expl Ther. 270, 310-317.
15. Arneric, S. P., Holladay, M. W. and Sullivan, J. P. (1996) Cholinergic channel modulators as a novel therapeutic strategy for Alzheimer's disease. Exp. Opin. Invest. Drugs 5, 79-100.
16. Aubert, I., Araujo, D. M., Cécyre, D., Robitaille, Y., Gauthier, S. and Quirion, R. (1992) Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J. Neurochem. 58, 529-541.
17. Badio, B., Shi, D., Shin, Y., Hutchinson, K. D., Padgett, W. L. and Daly, J. W. (1996) Spiropyrrolizidines: a new class of blockers of nicotinic receptors. Biochem. Pharmacol. 52, 933-939.
18. Badio, B., Padgett, W. L. and Daly, J. W. (1997) Ibogaine: a potent non-competitive blocker of ganglionic/neuronal nicotinic receptors. Mol. Pharmacol. 51, 1-5.
19. Balfour, D. J. K. and Fagerström, K. O. (1996) Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol. Ther. 72, 51-81.
20. Bencherif, M., Lovette, M. E., Fowler, K. W., Arrington, S., Reeves, L., Caldwell, W. S. and Lippiello, P. M. (1996) RJR-2403: a nicotinic agonist with CNS selectivity 1. In vitro characterization. J. Pharmacol. Expl Ther. 279, 1413-1421.
21. 3H]nicotine binding sites in human brain. J. Neurochem. 50, 1243-1247.
22. Bessis, A., Salmon, A. M., Zoli, M., Le Novère, N., Picciotto, M. and Changeux, J. P. (1995) Promoter elements conferring neuron-specific expression of the beta 2 subunit of the neuronal nicotinic acetylcholine receptor studied in vitro and in transgenic mice. Neuroscience 69, 807-819.
23. Bierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P. and Davis, K. L. (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64, 749-760.
24. Bertrand, D., Valera, S., Bertrand, S., Ballivet, M. and Rungger, D. (1991) Steroids inhibit nicotinic acetylcholine receptors. NeuroReport 2, 277-280.
25. Bertrand, D., Bertrand, S. and Ballivet, M. (1992) Pharmacological properties of the homomeric α7 receptor. Neurosci. Lett. 146, 87-90.
26. Bertrand, D., Galzi, J.-L., Devillers-Thiéry, A., Bertrand, S. and Changeux, J.-P. (1993) Stratification of the channel domain in neurotransmitter receptors. Curr. Opin. Cell Biol. 5, 688-693.
27. 2+. J. Pharmacol. Expl Ther. 277, 432-444.
28. Bovet, D., Bovet-Nitti, F. and Oliverio, A. (1966) Effects of nicotine on avoidance conditioning of imbred strains of mice. Psychopharmacologia 10, 1-5.
29. Boyd, R. T. (1994) Sequencing and promoter analysis of the genomic region between the rat neuronal nicotinic acetylcholine receptor beta 4 and alpha 3 genes. J. Neurobiol. 25, 960-973.
30. Briggs, C. A., McKenna, D. G. and Piattoni-Kaplan, M. (1995) Human α7 nicotinic acetylcholine receptor responses to novel ligands. Neuropharmacology 34, 583-590.
31. Briggs, C. A. and McKenna, D. G. (1996) Effect of MK-801 at the human α7 nicotinic acetylcholine receptor. Neuropharmacology 35, 407-414.
32. Brown, D. A. and Fumagalli, L. (1977) Dissociation of α-bungarotoxin binding and receptor block in the rat superior cervical ganglion. Brain Res. 129, 165-168.
33. Buccafusco, J. J. (1996) The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmacol. Rev. 48, 179-211.
34. 3H](-)nicotine binding sites in fetal human brain. Brain Res. 475, 1-7.
35. Candy, J. M., Perry, R. H., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F. and Tomlinson, B. E. (1983) Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J. Neurol. Sci. 59, 277-289.
36. Candy, J. M., Perry, E. K., Perry, R. H., Court, J. A., Oakley, A. E. and Edwardson, J. A. (1986) The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. In: Progress in Brain Research. Vol. 70, pp. 105-132. Eds D. F. Swaab, E. Fliers, M. Mirmiran, W. A. Van Gool and F. Van Haaren. Elsevier Science Publishers BV: London.
37. Cartier, G. E., Yoshikami, D., Gray, W. R., Luo, S., Olivera, B. and McIntosh, J. M. (1996) A new a-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J. Biol. Chem. 271, 7522-7528.
38. Cattaneo, M. G., Codignola, A., Vicentini, L. M., Clementi, F. and Sher, E. (1993) Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma. Cancer Res. 53, 5566-5568.
39. Chavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J. and Johnson, E. C. (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β4 and hα7 expressed in Xenopus oocytes. J. Pharmacol. Expl Ther. 280, 346-356.
40. Chiappinelli, V. A. (1983) Kappa-bungarotoxin: a probe for the neuronal nicotinic receptor in the avian ciliary ganglion. Brain Res. 277, 9-21.
41. Chiappinelli, V. A. (1993) Neurotoxins acting on acetylcholine receptors. In: Natural and Synthetic Neurotoxins, pp. 66-128. Ed. A. L. Harvey. Academic Press: London.
42. Chini, B., Clementi, F., Hukovic, N. and Sher, E. (1992) Neuronaltype α-bungarotoxin receptors and the α5-nicotinic receptor subunit gene are expressed in neuronal and non-neuronal human cells lines. Proc. natn. Acad. Sci. U.S.A. 89, 1572-1576.
43. Chini, B., Raimondi, E., Elgoyhen, A., Moralli, D., Balzaretti, M. and Heinemann, S. (1994) Molecular cloning and chromosomal localization of the human α7-nicotinic receptor subunit gene. Genomics 19, 379-381.
44. Cimino, M., Marini, P., Fornasari, D., Cattabeni, F. and Clementi, F. (1992) Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: localization of α3 subunit mRNA, α-Bungarotoxin and nicotine binding sites. Neuroscience 51, 77-86.
45. Cimino, M., Marini, P., Colombo, S., Andena, M., Cattabeni, F., Fornasari, D. and Clementi, F. (1994) Expression of neuronal acetylcholine nicotinic receptor α4 and β2 subunits during postnatal development of the rat brain. J. Neural Transm. 100, 77-92.
46. Clarke, P. B. (1993) Nicotinic receptors in mammalian brain: localization and relation onto cholinergic functions. Progr. Brain Res. 98, 77-83.
47. Clarke, P. B. S., Chaudieu, I., el-Bizri, H., Boksa, P., Quik, M., Esplin, B. A. and Capek, R. (1994) The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. Br. J. Pharmacol. 111, 397-405.
48. 3H]-dopamine release. Br. J. Pharmacol. 117, 595-606.
49. Clementi, F., Cabrini, D., Gotti, C. and Sher, E. (1986) Pharmacological characterization of cholinergic receptors in a human neuroblastoma cell line. J. Neurochem. 47, 291-297.
50. Codignola, A., Tarroni, P., Cattaneo, M. G., Vicentini, L. M., Clementi, F. and Sher, E. (1994) Serotonin release and cell proliferation are under the control of α-bungarotoxin-sensitive nicotinic receptors in small-cell lung carcinoma cell lines. FEBS Lett. 342, 286-290.
51. Codignola, A., McIntosh, J. M., Cattaneo, M. G., Vicentini, L. M., Clementi, F. and Sher, E. (1996) α-Conotoxin Imperialis I inhibits nicotine-evoked hormone release and cell proliferation in human neuroendocrine carcinoma cells. Neurosci. Lett. 206, 53-56.
52. Collins, A. C. and Marks, M. J. (1991) Progress towards the development of animal models of smoking-related behaviors. J. Addict. Dis. 10, 109-126.
53. Colrain, I. M., Mangou, G. L., Pellet, O. L. and Bates, T. C. (1992) Effects of post learning smoking on memory consolidation. Psychopharmacology 108, 448-451.
54. Conroy, W. G., Vernallis, A. B. and Berg, D. K. (1992) The α5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain. Neuron 9, 679-691.
55. Conroy, W. G. and Berg, D. K. (1995) Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J. Biol. Chem. 270, 4424-4431.
56. Conti-Tronconi, B. M., Dunn, S. M. J., Barnard, E. A., Dolly, J. O. and Lai, F. A. (1985) Brain and muscle nicotinic acetylcholine receptors are different but homologous proteins. Proc. natn. Acad. Sci. U.S.A. 82, 5208-5212.
57. Cooper, E., Couturier, S. and Ballivet, M. (1991) Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350, 235-238.
58. Corriveau, R. A., Romano, S. J., Conroy, W. G., Oliva, W. G. and Berg, D. K. (1995) Expression of neuronal acetylcholine receptor genes in vertebrate skeletal muscle during development. J. Neurosci. 15, 1372-1382.
59. Court, J. and Clementi, F. (1995) Distribution of nicotinic subtypes in human brain. Alzheimer Dis. Assoc. Disord. 9(suppl. 2), 6-14.
60. Court, J., Perry, E. K., Spurden, D., Griffiths, M., Kerwin, J. M., Morris, C. M., Johnson, M., Oakley, A. E., Bridsall, N. J. M., Clementi, F. and Perry, R. H. (1995) The role of cholinergic system in the development of the human cerebellum. Dev. Brain Res. 90, 159-167.
61. Couturier, S., Bertrand, D., Matter, J.-M., Hernandez, M. C., Bertrand, S., Millar, N., Valera, S. and Barkas, T. (1990) A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-btx. Neuron 5, 847-856.
62. Cross, K. M. L., Foreman, R. C. and Chad, J. E. (1995) Enhancement by 5-hydroxytryptamine and analogues of desensitization of neuronal and muscle nicotinic receptors expressed in Xenopus oocytes. Br. J. Pharmacol. 114, 1636-1640.
63. Dani, J. A. and Heinemann, S. (1996) Molecular and cellular aspects of nicotine abuse. Neuron 16, 905-908.
64. Danober, L., Depaulis, A., Marescaux, C. and Vergnes, M. (1993) Effects of cholinergic drugs on genetic absence seizures in rats. Eur. J. Pharmacol. 234, 263-268.
65. Daubas, P., Salmon, A.-M., Zoli, M., Geoffroy, B., Devillers-Thiéry, A., Bessis, A., Médevielle, F. and Changeux, J.-P. (1993) Chicken neuronal acetylcholine receptor α2-subunit gene exhibits neuron-specific expression in the brain and spinal cord of transgenic mice. Proc. natn. Acad. Sci. U.S.A. 90, 2237-2241.
66. Davies, P. and Maloney, A. J. F. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2, 1403.
67. Decker, M. W., Brioni, J. D., Bannon, A. W. and Arneric, S. P. (1995) Diversity of neuronal nicotinici acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci. 56, 545-570.
68. 125I-α-bungarotoxin receptor subtypes. Mol. Pharmacol. 47, 164-171.
69. De la Garza, A., Bickford-Wimer, P. C., Hoffer, B. J. and Freedman, R. (1987) Heterogeneity of nicotine actions in the rat cerebellum: an in vivo eletrophysiologic study. J. Pharmacol. Expl Ther. 240, 689-695.
70. Delbono, O., Gopalakrishnan, M., Renganathan, M., Monteggia, L. M., Messi, M. L. and Sullivan, J. P. (1997) Activation of the recombinant human α7 nicotinic acetylcholine receptor significantly raises intracellular free calcium. J. Pharmacol. Expl Ther. 280, 428-438.
71. Devillers-Thiéry, A., Galzi, J. L., Eiselé, J. L., Bertrand, S. and Changeux, J. P. (1993) Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels. J. Membr. Biol. 136, 97-112.
72. Dies, R. and Reznikoff, M. (1969) Personality and smoking patterns in a twin population. J. Proj. Tech. Pers. Assess. 33, 457-463.
73. Dominguez del Toro, E., Juiz, G. M., Peng, X., Lindstrom, J. and Criado, M. (1994) Immunocytochemical localization of the α7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J. Comp. Neurol. 349, 325-342.
74. Donnelly-Roberts, D. L., Arneric, S. P. and Sullivan, J. P. (1995) Functional modulation of human "ganglionic-like" neuronal nicotinic acetylcholine receptors (nAChRs) by L-type calcium channel antagonists. Biochem. Biophys. Res. Comm. 213, 657-662.
75. Dursun, S. M., Reveley, M. A., Bird, R. and Stirton, F. (1994) Long-lasting improvement of Tourette's syndrome with transdermal nicotine. Lancet 344, 1577.
76. Edwards, J. A. and Warburton, D. M. (1983) Smoking nicotine and electrocortical activity. Pharmacol. Ther. 19, 147-164.
77. El-Bizri, H. and Clarke, P. B. S. (1994a) Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br. J. Pharmacol. 111, 406-413.
78. El-Bizri, H. and Clarke, P. B. S. (1994b) Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine. Br. J. Pharmacol. 113, 917-925.
79. Elgoyhen, A. B., Johnson, D. S., Boulter, J., Vetter, D. E. and Heinemann, S. (1994) α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79, 705-715.
80. Elliott, K. J., Ellis, S. B., Berckhan, K. J., Urrutia, A., Chavez-Noriega, L. E., Johnson, E. C., Veliçelebi, G. and Harpold, M. M. (1996) Comparative structure of human neuronal α2-α7 and β2-β4 nicotinic acetylcholine receptor subunits and functional expression of the α2, α3, α4, α7, β2 and β4 subunits. J. Mol. Neurosci. 7, 217-228.
81. Eng, C. M., Kozak, C. A., Beaudet, A. L. and Zoghbi, H. Y. (1991) Mapping of multiple subunits of the neuronal nicotinic acetylcholine receptor to chromosome 15 in man and chromosome 9 in mouse. Genomics 9, 278-282.
82. Fels, G., Wolff, E. K. and Maelicke, A. (1982) Equilibrium binding of acetylcholine to the membrane-bound acetylcholine receptor. Eur.J. Biochem. 127, 31-38.
83. Fibiger, H. C. (1982) The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res. Rev. 4, 327-388.
84. 3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal. J. Neurochem. 47, 1948-1954.
85. Fornasari, D., Chini, B., Tarroni, P. and Clementi, F. (1990) Molecular cloning of human neuronal nicotinic receptor α3-subunit. Neurosci. Lett. 111, 351-356.
86. Fornasari, D., Battaglioli, E., Flora, A., Terzano, S. and Clementi, F. (1997) Structural and functional characterization of the human α3 nicotinic subunit gene promoter. Mol. Pharmacol. 51, 250-261.
87. Forsayeth, J. R. and Kobrin, E. (1997) Formation of oligomers containing the β3 and β4 subunits of the rat nicotinic receptor. J. Neurosci. 17, 1531-1538.
88. Fyodorov, D. and Deneris, E. (1996) The POU domain of SCIPT/ Tst-1/Oct-6 is sufficient for activation of an acetylcholine receptor promoter. Mol. Cell. Biol. 16, 5004-5014.
89. Freedman, R., Hall, M., Adler, L. E. and Leonard, S. (1995) Evidence in post-mortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiat. 38, 22-33.
90. Freedman, R., Coon, H., Mylesworsley, M., Orrutreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M. C., Reimherr, F., Wender, P., Yaw, J., Young, D. A., Breese, C. R., Adams, C., Patterson, D., Adler, L. E., Kruglyak, L., Leonard, S. and Byerley, W. (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. natn. Acad. Sci. U.S.A. 94, 587-592.
91. Galzi, J.-L. and Changeux, J.-P. (1995) Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology 34, 563-582.
92. Gandia, L., Villarroya, M., Sala, F., Reig, J.-A., Viniegra, S., Quintanar, J.-L., Garcia, A. G. and Gutierrez, L.-M. (1996) Inhibition of nicotinic receptor-mediated responses in bovine chromaffin cells by diltiazem. Br. J. Pharmacol. 118, 1301-1307.
93. Garcia-Colunga, J. and Miledi, R. (1995) Effects of serotonergic agents on neuronal nicotinic acetylcholine receptors. Proc. natn. Acad. Sci. U.S.A. 92, 2919-2923.
94. Gerzanich, V., Anand, R. and Lindstrom, J. (1994) Homomers of α8 and α7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol. Pharmacol. 45, 212-220.
95. Gerzanich, V., Peng, X., Wang, F., Wells, G., Anand, R., Fletcher, S. and Lindstrom, J. (1995) Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48, 774-782.
96. Gopalakrishnan, M., Buisson, B., Tourna, E., Giordano, T., Campbell, J. E., Hu, I. C., Donnelly-Roberts, D., Arneric, S. P., Bertrand, D. and Sullivan, J. P. (1995) Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor. Eur. J. Pharmacol. 290, 237-246.
97. Gopalakrishnan, M., Monteggia, L. M., Anderson, D. J., Molinari, E. J., Piattoni-Kaplan, M., Donnelly-Roberts, D., Arneric, S. P. and Sullivan, J. P. (1996) Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J. Pharmacol. Expl Ther. 276, 289-297.
98. Gotti, C., Wanke, E., Sher, E., Fornasari, D., Cabrini, D. and Clementi, F. (1986) Acetylcholine operated ion channel and α-bungarotoxin binding site in a human neuroblastoma cell line reside on different molecules. Biochem. Biophys. Res. Comm. 137, 1141-1147.
99. Gotti, C., Sher, E., Cabrini, D., Bondiolotti, G., Wanke, E., Mancinelli, E. and Clementi, F. (1987) Cholinergic receptors, ion channels, neurotransmitter synthesis, and neurite outgrowth are independently regulated during the in vitro differentiation of a human neuroblastoma cell line. Differentiation 34, 144-155.
100. Gotti, C., Esparis Ogando, A. and Clementi, F. (1989) The α-bungarotoxin receptor purified from a human neuroblastoma cell line: biochemical and immunological characterization. Neuroscience 32, 759-767.
101. Gotti, C., Esparis Ogando, A., Hanke, W., Schlue, Moretti, M. and Clementi, F. (1991) Purification and characterization of an α-bungarotoxin receptor that forms a functional nicotinic channel. Proc. natn. Acad. U.S.A. 88, 3258-3262.
102. Gotti, C., Hanke, W., Moretti, M., Ballivet, M., Clementi, F. and Bertrand, D. (1994) Pharmacology and biophysical properties of α7 and α7-α8 α-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur. J. Neurosci. 6, 1281-1291.
103. Gotti, C., Briscini, L., Verderio, C., Oortgiesen, M., Balestra, B. and Clementi, F. (1995) Native nicotinic acetylcholine receptors in human IMR32 neuroblastoma cells: functional, immunological and pharmacological properties. Eur. J. Neurosci. 7, 2083-2092.
104. Gotti, M., Moretti, M., Maggi, R., Longhi, R., Hanke, W., Klinke, N. and Clementi, F. (1997) α7 and α8 Nicotinic receptor subtypes immunopurified from chick retina have different immunological, pharmacological and functional properties. Eur. J. Neurosci. 5, 1201-1211.
105. Gould, J., Reeve, H. L., Vaughan, P. F. T. and Peers, C. (1992) Nicotinic acetylcholine receptors in human neuroblastoma (SH-SY5Y) cells. Neurosci. Lett. 145, 201-204.
106. Grady, S., Marks, M., Wonnacott, S. and Collins, A. C. (1992) Characterization of nicotinic receptor mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59, 848-856.
107. Grando, S. A., Horton, R. M., Pereira, E. F. R., Diethelm-Okita, B. M., George, P. M., Albuquerque, E. X. and Conti-Fine, B. M. (1995) A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J. Invest. Dermatol. 105, 774-781.
108. Gray, R., Royan, A. S., Radcliffe, K. A., Yakehiro, M. and Dani, J. (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383, 733-716.
109. 3H]cytisine binding to humar. brain membrane preparations. Brain Res. 600, 127-133.
110. Halvorsen, S. W. and Berg, D. K. (1990) Subunit composition of nicotinic acetylcholine receptors from chick ciliary ganglia. J. Neurosci. 10, 1711-1718.
111. Halvorsen, S. W., Jiang, N. and Malek, R. (1995) Regulation of nicotinic acetylcholine receptors on human neuroblastoma cells during differentiation. Biochem. Pharmacol. 50, 1665-1671.
112. Halvorsen, S. W., Malek, R., Wang, X. and Jiang, N. (1996) Ciliary neurotrophic factor regulates nicotinic acetylcholine receptors on human neuroblastoma cells. Neuropharmacology 35, 257-265.
113. Harvey, S. C. and Luetje, C. W. (1996) Determinant of competitive antagonist sensitivity on neuronal nicotinic receptor β subunits. J. Neurosci. 16, 3798-3806.
114. Hatsukami, D., Fletcher, L., Morgan, S., Keenan, R., and Amble, P. (1989) The effects of varying cigarette deprivation duration on cognitive and performance tasks. J. Subst. Abuse 1, 407-416.
115. Heimstra, N. W., Bancroft, N. R. and DeKock, A. R. (1967) Effects of smoking upon sustained performance in a simulated driving task. Ann. NY Acad. Sci. 142, 295-307.
116. Heimstra, N. W., Fallesen, J. J., Kinsley, S. A. and Warner, N. W. (1980) The effects of deprivation of cigarette smoking on psychomotor performance. Ergonomics 23, 1047-1055.
117. Hernandez, M. C., Erkman, L., Matter-Sadzinski, L., Roztocil, T., Ballivet, M. and Matter, J. M. (1995) Characterization of the nicotinic acetylcholine receptor beta 3 gene. Its regulation within the avian nervous system is effected by a promoter 143 base pairs in length. J. Biol. Chem. 270, 3224-3233.
118. Hindmarch, I., Kerr, J. S. and Sherwood, N. (1990) Effects of nicotine gum on psychomotor performance in smokers and non-smokers. Psychopharmacology 100, 535-541.
119. Hindmarch, I. and Sherwood, N. (1995) Nicotine and cognitive effects. In: Advances in Pharmacological Sciences. Effects of Nicotine on Biological Systems II, pp. 189-194. Eds P. B. S. Clarke, M. Quik and K. Thurau. Birkhäuser Verlag: Basel.
120. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol. Pharmacol. 48, 280-287.
121. Hu, M., Whiting Theobald, N. L. and Gardner, P. D. (1994) Nerve growth factor increases the transcriptional activity of the rat neuronal nicotinic acetylcholine receptor beta 4 subunit promoter in transfected PC12 cells. J. Neurochem. 62, 392-395.
122. Hu, M., Bigger, C. B. and Gardner, P. D. (1995) A novel regulatory element of a nicotinic acetylcholine receptor gene interacts with a DNA binding activity enriched in rat brain. J. Biol. Chem. 270, 4497-4502.
123. Hughes, J. R. and McHugh, P. (1995) Nicotine and neuropsychiatrie disorders: schizophrenia. In: Advances in Pharmacological Sciences. Effects of Nicotine on Biological Systems II, pp. 301-305. Eds P. B. S. Clarke, M. Quik, F. Adlkofer and K. Thurau. Birkhäuser Verlag: Basel.
124. Hussy, N., Ballivet, M. and Bertrand, D. (1994) Agonist and antagonist effects of nicotine on chick neuronal nicotinic receptors are defined by alpha and beta subunits. J. Neurophysiol. 72, 1317-1326.
125. Jacob, M. H. and Berg, D. K. (1983) The ultrastructural localization of α-bungarotoxin binding sites in relation to synapses on chick ciliary ganglion neurons. J. Neurosci. 3, 260-271.
126. James, J. R. and Nordberg, A. (1995) Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. Behav. Genet. 25, 149-159.
127. Johnson, D. S., Martinez, J., Elgoyhen, A. B., Heinemann, S. F. and McIntosh, J. M. (1995) α-Conotoxin Iml exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric α7 and α9 receptors. Mol. Pharmacol. 48, 194-199.
128. Jones, G. M. M., Sahakian, B. J., Levy, R., Warburton, D. M. and Gray, J. A. (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108, 485-494.
129. Joy, A. M., Siegel, H. N. and Lukas, R. J. (1993) Photoaffinity labeling of muscle-type nicotinic acetylcholine receptors and neuronal/nicotinic α-bungarotoxin binding sites with a derivative of α-bungarotoxin. Mol. Brain Res. 17, 95-100.
130. Karlin, A. and Akabas, M. H. (1995) Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15, 1231-1244.
131. Ke, L. and Lukas, R. J. (1996) Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes. J. Neurochem. 67, 1100-1112.
132. Keyser, K. T., Britto, L. R., Schoepfer, R., Whiting, P., Cooper, J., Conroy, W., Brozozowska-Prechtl, A., Karten, H. J. and Lindstrom, J. (1993) Three subtypes of α-bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina. J. Neurosci. 13, 442-454.
133. 3H]nicotine binding in the human brainstem. Neuroscience 55, 1127-1138.
134. Knopman, D., Schneider, L., Davis, K., Talwalker, S., Smith, F., Hoover, T., Gracon, S. and the Tacrine Study Group (1996) Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality. Neurology 47, 166-177.
135. Koyama, K., Sudo, K. and Nakamura, Y. (1994) Mapping of the human nicotinic acetylcholine receptor β3 gene (CHRNB3) within chromosome 8p 11.2. Genomics 21, 460-461.
136. Lange, K. W., Wells, F. R., Jenner, P. and Marsden, C. D. (1993) Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease. J. Neurochem. 60, 197-203.
137. Le Novère, N. and Changeux, J.-P. (1995) Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J. Mol. Evol. 40, 155-172.
138. Leonard, S., Adams, C., Breese, C., Adler, L., Bickford, P., Byerley, W., Coon, H., Griffith, J., Miller, C., Nayamoto, H., Rollins, Y., Stevens, K. E., Waldo, M. and Friedman, R. (1996) Nicotinic receptors function in schizophrenia. Schizophrenia 22, 341-445.
139. Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H. and Murphy, D. L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
140. Levin, E. D. (1992) Nicotinic systems and cognitive function. Psychopharmacology 108, 417-431.
141. Lindstrom, J., Schoepfer, R. and Whiting, P. (1987) Molecular studies of the neuronal nicotinic acetylcholine receptor family. Mol. Neurobiol. 1, 281-337.
142. Lipton, S. A. and Kater, S. B. (1989) Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci. 12, 265-270.
143. Lohr, J. B. and Flynn, K. (1992) Smoking and schizophrenia. Schizophrenia Res. 8, 93-102.
144. Luetje, C. W., Wada, K., Rogers, S., Abramson, S. N., Tsuji, K., Heinemann, S. and Patrick, J. (1990) Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J. Neurochem. 55, 632-640.
145. Luetje, C. W. and Patrick, J. (1991) Both α-and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11, 837-845.
146. Luetje, C. W., Piattoni, M. and Patrick, J. (1993) Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric α subunits. Mol. Pharmacol. 44, 657-666.
147. Lukas, R. J. and Cullen, M. J. (1988) An isotopic rubidium ion efflux assay for the functional characterization of nicotinic acetylcholine receptors on clonal cell lines. Anal. Biochem. 175, 212-218.
148. Lukas, R. J. and Bencherif, M. (1992) Heterogeneity and regulation of nicotinic acetylcholine receptors. Intl Rev. Neurobiol. 341, 25-131.
149. Lukas, R. J. (1993) Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line. J. Pharmacol. Expl Ther. 265, 294-302.
150. Lukas, R. J., Norman, S. A. and Lucero, L. (1993) Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol. Cell. Neurosci. 4, 1-12.
151. Maneckjee, R. and Minna, J. D. (1990) Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. natn. Acad. Sci. U.S.A. 87, 3294-3298.
152. Marks, M. J., Stitzel, J. A. and Collins, A. C. (1989) Genetic influences on nicotine responses. Pharmacol. Biochem. Behav. 33, 667-678.
153. Marks, M. J., Pauly, J. R., Gross, S. D., Deneris, E. S., Hermans-Borgmeyer, I., Heinemann, S. F. and Collins, A. C. (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12, 2765-2784.
154. Marks, M. J., Farnhal, D. A., Grady, S. R. and Collins, A. C. (1993) Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J. Pharmacol. Expl Ther. 264, 542-552.
155. Marks, M. J., Pauly, J. R., Grun, E. U. and Collins, A. C. (1996a) ST/b and DBA/2 mice differ in brain a-bungarotoxin binding and α7 nicotinic receptor subunit mRNA levels: a quantitative autoradiographic analysis. Mol. Brain Res. 39, 207-222.
156. Marks, M. J., Robinson, S. F. and Collins, A. C. (1996b) Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes. J. Pharmacol. Expl Ther. 277, 1383-1396.
157. Marshall, L. M. (1981) Synaptic localization of α-bungarotoxin binding which blocks nicotinic transmission in frog sympathetic neurons. Proc. natn. Acad. Sci. U.S.A. 78, 1948-1952.
158. Martin, B. R., Onaivi, E. S. and Martin, T. J. (1989) What is the nature of mecamylamine's antagonism of the central effects of nicotine? Biochem.
159. Matter, J. M., Matter-Sadzinski, L. and Ballivet, M. (1995) Activity of the beta 3 nicotinic receptor promoter is a marker of neuron fate determination during retina development. J. Neurosci. 15, 5919-5928.
160. Matter-Sadzinski, L., Hernandez, M. C., Roztocil, T., Ballivet, M. and Matter, J. M. (1992) Neuronal specificity of the alpha 7 nicotinic acetylcholine receptor promoter develops during morphogenesis of the central nervous system. EMBO J. 11, 4529-4538.
161. Matsubayashi, H., Alkondon, M. and Albuquerque, E. X. (1996) Inhibitory effects of strychnine on nicotinic acetylcholine responses of cultured rat hippocampal neuron. Soc. Neurosci. Abstracts 22, 502.23.
162. McConville, B. J., Fogelson, M. H., Norman, A. B., Klykylo, W. M., Manderscheid, P. Z., Parker, K. W. and Sanberg, P. R. (1991) Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder. Am. J. Psychiat. 148, 793-794.
163. McConville, B. J., Sanberg, P. R., Fogelson, M. H., King, J., Cirino, P., Parker, K. W. and Norman, A. B. (1992) The effects of nicotine plus haloperidol compared to nicotine only in reducing tic severity and frequency in Tourette's disorder. Biol. Psychiat. 31, 832-840.
164. McGehee, D. S. and Role, L. W. (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57, 521-546.
165. McGehee, D. S., Heath, M. J., Gelber, S., Devay, P. and Role, L. W. (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269, 1692-1696.
166. McGehee, D. S. and Role, L. W. (1996) Presynaptic ionotropic receptors. Curr. Opin. Neurobiol. 6, 342-349.
167. Mesulam, M. M. and Geula, C. (1988) Nucleus basalis and cortical cholinergic innervation in the human brain: observations based on the distribution of AChE and ChAT. J. Comp. Neurol. 275, 216-240.
168. Mesulam, M. M., Geula, C., Botwell, M. A. and Hersch, L. B. (1989) Human reticular formation: cholinergic neurons of the peduncolopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J. Comp. Neurol. 281, 611-633.
169. Mesulam, M. M. (1995) Cholinergic pathways and the ascending reticular activating system of the human brain. Ann. NY Acad. Sci. 757, 169-179.
170. Mihovilovic, M. and Roses, A. D. (1991) Expression of mRNAs in human thymus coding for the α3 subunit of a neuronal acetylcholine receptor. Expl Neurol. 111, 175-180.
171. Mihovilovic, M., Hulette, C., Mittelstaedt, J., Austin, C. and Roses, A. D. (1993a) Nicotinic neuronal acetylcholine receptor α3 subunit transcription in normal and myasthenic thymus. Ann. NY Acad. Sci. 681, 83-96.
172. Mihovilovic, M., Mai, Y., Herbstreith, M., Rubboli, F., Tarroni, P., Clementi, F. and Roses, A. D. (1993b) Splicing of an antisense Alu sequence generates a coding sequence variant for the α3 subunit of a neuronal acetylcholine receptors. Biochem. Biophys. Res. Comm. 197, 137-144.
173. Milton, N. G., Bessis, A., Changeux, J. P. and Latchman, D. S. (1995) The neuronal nicotinic acetylcholine receptor alpha 2 subunit gene promoter is activated by the Brn-3b POU family transcription factor and not by Brn-3a or Brn-3c. J. Biol. Chem. 270, 15143-15147.
174. Milton, N. G., Bessis, A., Changeux, J. P. and Latchman, D. S. (1996) Differential regulation of neuronal nicotinic acetylcholine receptor subunit gene promoters by Brn-3 POU family transcription factors. Biochem. J. 317, 419-423.
175. Monteggia, L. M., Gopalakrishnan, M., Tourna, E., Idler, K. B., Nash, N., Arneric, S. P., Sullivan, J. P. and Giordano, T. (1995) Cloning and transient expression of genes encoding the human α4 and β2 neuronal nicotinic acetylcholine receptor (nAChR) subunits. Gene 155, 189-193.
176. Mukherjee, S., Mahadik, S. P., Korenovscky, A., Laev, H., Schnur, D. B. and Reddy, R. (1994) Serum antibodies to nicotinic acetylcholine receptors in schizophrenic patients. Schizophrenia Res. 12, 131-136.
177. Nagata, K., Aistrup, G. L., Huang, C.-S., Marszalec, W., Song, J.-H., Yeh, J. Z. and Narahashi, T. (1996) Potent modulation of neuronal nicotinic acetylcholine receptor-channel by ethanol. Neurosci. Lett. 217, 189-193.
178. Newhouse, P. A., Sunderland, T., Narang, P. K., Mellow, A. M., Fertig, J. B., Lawlor, B. A. and Murphy, D. L. (1990) Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in non-smoking healthy volunteers and in patients with Alzheimer's disease. Psychoneuroendocrinology 15, 471-484.
179. Newhouse, P. A., Potter, A., Corwin, J. and Lenox, R. (1992) Acute nicotinic blockade produces cognitive impairment in normal humans. Psychopharmacology 108, 480-484.
180. Newhouse, P. A., Potter, A., Piasecki, M., Geebmuyden, J., Corwin, J. and Lenox, R. (1995) Nicotinic modulation of cognitive function in humans. In: Advances in Pharmacological Sciences. Effects of Nicotine on Biological Systems II, pp. 345-351. Eds P. B. S. Clarke, M. Quik and K. Thurau. Birkhäuser Verlag: Basel.
181. Nisell, M., Nomikos, G. G. and Svensson, T. H. (1995) Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacol. Toxicol. 76, 157-162.
182. Nordberg, A. and Winblad, B. (1986) Brain nicotinic and muscarinic receptors in normal aging and dementia. In: Alzheimer's and Parkinson's Disease: Strategies for Research and Development, pp. 95-108. Eds A. Fisher, I. Hanin and C. Lachman. Plenum Press: New York.
183. Nordberg, A., Adem, A., Bucht, G., Viitanen, M. and Winblad, B. (1990a) Alterations in lymphocyte receptor densities in dementia of Alzheimer type: a possible diagnostic marker. In: Biological Markers in Dementia of Alzheimer Type, pp. 149-159. Eds C. J. Fowler et al. Smith-Gordon: London.
184. Nordberg, A., Hartvig, P., Lilja, A., Viitanen, M., Amberla, K., Lundqvist, H., Andersson, Y., Ulin, J., Winblad, B. and Langstrom, B. (1990b) Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J. Neural Transm. 2, 215-224.
185. Nordberg, A., Alafuzoff, I. and Winblad, B. (1992) Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res. 31, 103-111.
186. Nordberg, A. (1993) Clinical studies in Alzheimer patients with positron emission tomography. Behav. Brain Res. 57, 215-224.
187. Nordberg, A. (1995) Imaging of nicotinic receptors in human brain. In: Brain Imaging of Nicotine and Tobacco Smoking, pp. 45-57. Ed. E. F. Domino. NPP Books: Ann Arbor, MI.
188. Nordberg, A., Lundqvist, H., Hartvig, P., Lilja, A. and Langstrom, B. (1995) Kinetic analysis of regional (S) (-) 11C-nicotine binding in normal and Alzheimer brains. In vivo assessment using positron emission tomography. Alzheimer's Dis. Assoc. Disord. 9, 21-27.
189. Paldi-Haris, P., Szelenyi, J. G., Nguyen, T. H. and Hollan, S. R. (1990) Changes in the expression of the cholinergic structures of human T lymphocytes due to maturation and stimulation. Thymus 16, 119-122.
190. Palma, E., Mileo, A. M., Eusebi, F. and Miledi, R. (1996) Threonine-for-leucine mutation within domain M2 of the neuronal α7 nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist. Proc. natn. Acad. Sci. U.S.A. 93, 11231-11235.
191. Papke, R. L. and Heinemann, S. F. (1991) The role of the β4-subunit in determining the kinetic properties of rat neuronal nicotinic acetylcholine α3-receptors. J. Physiol. 440, 95-112.
192. Papke, R. L. (1993) The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity. Progr. Neurobiol. 41, 509-531.
193. Papke, R. L. and Heinemann, S. F. (1993) Partial agonist properties of cytisine on neuronal nicotinic acetylcholine α3-receptors. Mol. Pharmacol. 45, 142-149.
194. Papke, R. L., Duvoisin, R. M. and Heinemann, S. F. (1993) The amino terminal half of the nicotinic β-subunit extracellular domain regulates the kinetics of inhibition by neuronal bungarotoxin. Proc. R. Soc. London Ser. B 252, 141-148.
195. Pauly, J. R., Marks, M. J., Robinson, S. F., van de Kamp, J. L. and Collins, A. C. (1996) Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing α4 or β2 mRNA levels. J. Pharmacol. Expl Ther. 278, 361-369.
196. Pedersen, N. (1981) Twin similarity for usage of common drugs. In: Twin Research 3: Epidemiological and Clinical Studies, pp. 53-59. Eds L. Gedda, P. Parisi and W. E. Nance. Alan R. Liss: New York.
197. Peng, X., Gerzanich, V., Anand, R., Whiting, P. J. and Lindstrom, J. (1994a) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46, 523-530.
198. Peng, X., Katz, M., Gerzanich, V., Anand, R. and Lindstrom, J. (1994b) Human α7 acetylcholine receptor: cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional α7 homomers expressed in Xenopus oocytes. Mol. Pharmacol. 45, 546-554.
199. Pereira, E. F. R., Alkondon, M., Reinhardt, S., Maelicke, A., Peng, X., Londstrom, J., Whiting, P. and Albuquerque, E. X. (1994) Physostigmine and galanthamine: probes for a novel binding site on the α4β2 subtype of neuronal nicctinic acetylcholine receptors stably expressed in fibroblast cells. J. Pharmacol. Expl Ther. 270, 768-778.
200. Pereira, E. F. R., Alkondon, M., McIntosh, M. and Albuquerque. E. X. (1996) α-Conotoxin-Iml: a competitive antagonist at α-bungarotoxin-sensitive neuronal nicotinic receptors in hippocampal neurons. J. Pharmacol. Expl Ther. 278, 1472-1483.
201. Perry, R. H., Candy, J., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F. and Tomlinson, B. E. (1982) Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci. Lett. 33, 311-315.
202. Perry, R. H., Tomlinson, B. E., Candy, J. M., Blessed, G., Foster, J. F., Bloxham, C. A. and Perry, E. K. (1983) Cortical cholinergic deficit in mentally impaired parkinsonian patients. Lancet 2, 789-790.
203. Perry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., Blessed, G., Fairbairn, A., Tomlinson, B. E. and Perry, R. H. (1985) Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J. Neurol. Neurosurg. Psychiat. 48, 413-421.
204. Perry, E. K., Smith, C. J., Perry, R. H., Whitford, C., Johnson, M. and Birdsall, N. J. (1989) Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain. J. Chem. Neuroanat. 2, 189-199.
205. 3H]nicotine binding in human cortex: relative abundance in subicular complex. J. Chem. Neuroanat. 5, 399-405.
206. Perry, E. K., Morris, C. M., Court, J. A., Cheng, A., Fairbairn, A. F., McKeith, I. G., Irving, D., Brown, A. and Perry, R. H. (1995) Alteration in nicotine binding sites in Parkinson's disease. Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 64, 385-395.
207. Phillips, H. A., Scheffer, I. E., Berkovic, S. F., Hollway, G. E., Sutherland, G. R. and Mulley, J. C. (1995) Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nature Genet. 10, 117-118.
208. Pich, E. M., Pagliusi, S. R., Tessari, M., Talabot-Ayer, D., Hoogt van Huijsduijnen, R. and Chiamulera, C. (1997) Common neural substrate for addictive properties of nicotine and cocaine. Science 275, 83-86.
209. Pickworth, W. B., Herning, R. I. and Henningfield, J. E. (1988) Mecamylamine reduces some EEG effects of nicotine chewing gum in humans. Pharmacol. Biochem. Behav. 30, 149-153.
210. Pontieri, F. E., Tanda, G., Orzi, F. and Di Chiara, G. (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382, 255-257.
211. Pough, P. C. and Berg, D. K. (1994) Neuronal acetylcholine receptors that bind α-bungarotoxin mediate neurite retraction in a calcium-dependent manner. J. Neurosci. 14, 889-895.
212. Puchacz, E., Buisson, B., Bertrand, D. and Lukas, R. J. (1994) Functional expression of nicotinic acetylcholine receptors containing rat α7 subunits in human SH-SY5Y neuroblastoma cells. FEBS Lett. 354, 155-159.
213. Quik, M., Chan, J. and Patrick, J. (1994) α-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line. Brain Res. 655, 161-167.
214. Quik, M. (1995) Growth related role for the nicotinic α-bungarotoxin receptor. In: Advances in Pharmacological Sciences. Effects of Nicotine on Biological Systems II, pp. 145-150. Eds P. B. S. Clarke, M. Quik, F. Adlkofer and K. Thurau. Birkhäuser Verlag: Basel.
215. Quik, M., Choremis, J., Komourian, J., Lukas, R. J. and Puchacz, E. (1996) Similarity between rat brain nicotinic α-bungarotoxin receptors and stably expressed α-bungarotoxin binding sites. J. Neurochem. 67, 145-154.
216. Raaschou-Nielsen, E. (1960) Smoking habits in twins. Danish Med. Bull. 7, 82-88.
217. Raimondi, E., Rubboli, F., Moralli, D., Chini, B., Fornasari, D., Tarroni, P., De Carli, L. and Clementi, F. (1992) Chromosomal localization and physical linkage of the genes encoding the human α3, α5 and β4 neuronal nicotinic receptor subunits. Genomics 12, 849-850.
218. Ramirez-Latorre, J., Yu, C. R., Qu, Perin, F., Karlin, A. and Role. L. (1996) Functional contributions of α5 subunit to neuronal acetylcholine receptor channels. Nature 380, 347-351.
219. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 54, 937-945.
220. Richman, D. P. and Aarnason, G. W. (1979) Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytes. Proc. natn. Acad. Sci. U.S.A. 76, 4632-4635.
221. Rinne, J. O., Myllykyla, T., Lonnberg, P. and Marjamaki, P. (1991) A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res. 547, 167-170.
222. Rinner, L. Kukulansky, T., Felsner, P., Skreiner, E., Globerson, A., Kasai, M., Hirokawa, K., Korsatko, W. and Schauenstein, K. (1994) Cholinergic stimulation modulates apoptosis and differentiation of murine thymocytes via a nicotinic effect on thymic epithelium. Biochem. Biophys. Res. Comm. 203, 1057-1062.
223. Role, L. W. (1992) Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels, Curr. Opin. Neurobiol. 2, 254-262.
224. Role, L. W. and Berg, K. D. (1996) Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16, 1077-1085.
225. Rubboli, F., Court, J. A., Sala, C., Morris, C., Chini, B., Perry, E. and Clementi, F. (1994) Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur. J. Neurosci. 6, 1596-1604.
226. Sacaan, A. I., Reid, R. T., Santori, E. M., Adams, P., Correa, L. D., Mahaffy, L. S., Bleicher, L., Cosford, N. D. P., Stauderman, K. A., McDonald, I. A., Rao, T. S. and Lloyd, G. K. (1997) Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. J. Pharmacol. Expl Ther. 280, 373-383.
227. Sala, C., Kimura, I., Santoro, G., Kimura, M. and Fumagalli, G. (1996) Expression of two neuronal nicotinic receptor subunits in innervated and denervated adult rat muscle. Neurosci. Lett. 214, 1-4.
228. Sanberg, P. R., Fogelson, M. H., Manderscheid, P. Z., Parker, K. W., Norman, A. B. and McConville, B. J. (1988) Nicotine gum and haloperidol in Tourette's syndrome. Lancet 1, 592.
229. Saper, C. B. (1990) Cholinergic system. In: The Human Nervous System, pp. 1095-1113. Ed. G. Paxinos. Academic press, Inc.: New York.
230. Sargent, P. B. (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16, 403-443.
231. Sastry, B. V. and Sadavongvivad, C. (1979) Cholinergic systems in non-nervous tissues. Pharmacol. Rev. 30, 65-132.
232. Schoepfer, R., Conroy, W. G., Whiting, P., Gore, M. and Lindstrom, J. (1990) Brain α-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 5, 35-48.
233. Schrattenholz, A., Pereira, E. F. R., Roth, U., Weber, K.-H., Albuquerque, E. X. and Maelicke, A. (1996) Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol. Pharmacol. 49, 1-6.
234. Schröder, H., Zilles, K., Maelicke, A. and Hajos, F. (1989) Immunohisto-and cytochemical localization of cortical nicotinic cholinoceptors in rat and man. Brain Res. 502, 287-295.
235. Schröder, H., Giacobini, E., Struble, R. G., Zilles, K. and Maelicke, A. (1991) Nicotine cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease. Neurobiol. Aging 12, 259-262.
236. Schröder, H., de Vos, R. A. I., Jansen, E. N. H., Birtsch, C., Wevers, A., Lobron, C., Nowacki, S., Schröder, R. and Maelicke, A. (1995) Gene expression of the nicotinic acetylcholine receptor α4 subunit in the frontal cortex in Parkinson's disease patients. Neurosci. Lett. 187, 173-176.
237. Schröder, H., Wevers, A., Happich, E., Schütz, U., Moser, N., de Vos, R. A. I., van Noort, G., Jansen, E. N. H., Giacobini, E. and Maelicke, A. (1996) Molecular histochemistry of nicotinic receptors in human brain. In: Fourth International Nice/ Springfield Alzheimer Symposium. Eds R. Becker, E. Giacobini and P. Robert. Birkhäuser: Boston.
238. Schuller, H. M. (1989) Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cells lines by nicotine and tobacco-related nitrosamines. Biochem. Pharmacol. 38, 3439-3442.
239. Schuller, H. M. (1994) Carbon dioxide potentiates the mitogenic effects of nicotine and its carcinogenic derivative, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent mitogenic pathways. NeuroToxicology 15, 877-886.
240. Schulz, D. W., Kuchel, G. A. and Zigmond, R. E. (1993) Decline in response to nicotine in aged rat striatum: correlation with a decrease in a subpopulation of nicotinic receptors. J. Neurochem. 61, 2225-2232.
241. 3H-acetylcholine in rat brain. Mol. Pharmacol. 22, 56-62.
242. Séguéla, P., Wadiche, J., Dineley-Miller, K., Dani, J. A. and Patrick, J. W. (1993) Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13, 596-604.
243. Sherwood, N. (1995) Effects of cigarette smoking on performance in a simulated driving task. Neuropsychobiology 32, 161-165.
244. 3H]nicotine. J. Neurochem. 45, 605-610.
245. Silver, A. A., Shytle, R. D., Philipp, M. K. and Sanberg, P. R. (1995) Transdermal nicotine in Tourette's syndrome. In: Advances in Pharmacological Sciences. Effects of Nicotine on Biological Systems II, pp. 293-299. Eds P. B. S. Clarke, M. Quik, F. Adlkofer and K. Thurau. Birkhäuser Verlag: Basel.
246. Smolen, A. J. (1983) Specific binding of α-bungarotoxin into synaptic membranes in rat sympathetic ganglia. Brain Res. 289, 177-188.
247. 3H]dopamine release from rat striatal synaptosomes. Neuropharmacology 34, 1535-1541.
248. Stetzer, E., Ebbinghaus, U., Storch, A., Poteur, L., Schrattenholz, A., Kramer, G., Methfessel, C. and Maelicke, A. (1996) Stable expression in HEK-293 cells of the rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor. FEBS Lett. 397, 39-44.
249. Steinlein, P., Smigrodzki, R., Lindstrom, J., Anand, R., Kohler, M., Tocharoentanaphol, C. and Vogel, F. (1994) Refinement of the localization of the gene for neuronal nicotinic acetylcholine receptor α4 subunit (CHRNA4) to human chromosome 20q 13.2-q 13.3. Genomics 22, 493-495.
250. Steinlein, O. K., Mulley, J. C., Propping, P., Wallace, R. H., Phillips, H. A., Sutherland, G. R., Scheffer, I. E. and Berkovic, S. F. (1995) A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genet. 11, 201-203.
251. Stolerman, I. P. and Jarvis, M. I. (1995) The scientific case that nicotine is addictive. Psychopharmacology 117, 2-10.
252. Storch, A., Schrattenholz, A., Cooper, J. C., Ghani, E. M. A., Gutbrod, O., Weber, K.-H., Reinhardt, S., Lobron, C., Hermsen, B., Soskiç, V., Pereira, E. F. R., Albuquerque, E. X., Methfessel, C. and Maelicke, A. (1995) Physiostigmine, galanthamine and codeine act as "noncompetitive nicotinic receptor agonists" on clonal rat pheochromocytoma cells. Eur. J. Pharmacol. 290, 207-219.
253. Stroud, R. M., McCarthy, M. P. and Shuster, M. (1990) Nicotinic acetylcholine receptor superfamily of ligand-gated ion channels. Biochemistry 29, 11009-11023.
254. Sullivan, J. P., Decher, M. W., Brioni, J. D., Donnelly-Roberts, D., Anderson, H. D. J., Bannon, A. W., Kang, C.-H., Adams, P., Piattoni-Kaplan, M., Buckley, M. J., Gopalakrishnan, M., Williams, M. and Arneric, S. P. (1994) (±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J. Pharmacol. Expl Ther. 271, 624-631.
255. Tarroni, P., Rubboli, F., Chini, B., Zwart, R., Oortgiesen, M., Sher, E. and Clementi, F. (1992) Neuronal-type nicotinic receptors in human neuroblastoma and small-cell lung carcinoma cell lines. FEBS Lett. 312, 66-70.
256. Thomas, P., Stephens, M., Wilkie, G., Amar, M., Lunt, G. G., Whiting, P., Gallagher, T., Pereira, E., Alkondon, M., Albuquerque, E. X. and Wonnacott, S. (1993) (+)-Anatoxin-a is a potent agonist at neuronal nicotinic acetylcholine receptors. J. Neurochem. 60, 2308-2311.
257. Valera, S., Ballivet, M. and Bertrand, D. (1992) Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. natn. Acad. Sci. U.S.A. 89, 9949-9953.
258. Vaughan, P. F. T., Kaye, D. F., Reeve, H. L., Ball, S. G. and Peers, C. (1993) Nicotinic receptor-mediated release of noradrenaline in the human neuroblastoma SH-SY5Y. J. Neurochem. 60, 2159-2166.
259. Vernallis, A. B., Conroy, W. G. and Berg, D. K. (1993) Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron 10, 451-464.
260. Vijayaraghavan, S., Schmid, H. A. and Mapp, K. S. (1993) Serotonin modulates nicotinic responses of adrenal chromaffin cells. J. Neurochem. 61, 324-331.
261. Wada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J. and Swanson, L. W. (1989) Distribution of alpha2, alpha3, alpha4 aned beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284, 314-335.
262. Wang, F., Gerzanich, V., Wells, G. B., Anand, R., Peng, X., Keyser, K. and Lindstrom, J. (1996) Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2, and β4 subunits. J. Biol. Chem. 271, 17656-17665.
263. Warburton, D. M., Wesnes, K., Shergold, K. and James, M. (1986) Facilitation of learning and state dependency with nicotine. Psychopharmacology 89, 55-59.
264. Weiland, S., Witzemann, V., Villarroel, A., Propping, P. and Steinlein, O. (1996) An aminoacid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Lett. 398, 91-96.
265. Weiss, W. (1993) Epidemiology of lung cancer. In: Comparative Respiratory Tract Carcinogenesis, Ed. H. M. Reznik-Schüller. CRC Press: Boca Raton.
266. Weiss, W. (1991) COPD and lung cancer. In: Chronic Obstructive Pulmonary Disease, pp. 344-347. Ed. N. S. Cherniak. W. B. Saunders Co.: Philadelphia.
267. Wesnes, K. and Warburton, D. M. (1983) Effect of smoking on rapid information processing performance. Neuropsychobiology 9, 223-229.
268. West, R. J. and Jarvis, M. J. (1986) Effects of nicotine on finger tapping rate in non-smokers. Pharmacol. Biochem. Behav. 25, 727-731.
269. Wevers, A., Sullivan, J. P., Giordano, T., Birtsch, Ch., Monteggia, L. M., Nowacki, S., Arneric, S. and Schröder, H. (1995) Cellular distribution of the mRNA for the α7 subunit of the nicotinic acetylcholine receptor in the human cerebral cortex. Drug. Dev. Res. 36, 103-110.
270. Whitehouse, P. J., Martino, A. M., Antuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L. and Kellar, K. J. (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res. 371, 146-151.
271. 3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology 38, 720-723.
272. Whyte, J., Harrison, R., Lunt, G. G. and Wonnacott, S. (1985) Properties of α-bungarotoxin binding sites in foetal human brain. Neurochem. Intl 7, 515-523.
273. Whiting, P. and Lindstrom, J. (1986a) Purification and characterization of nicotinic acetylcholine receptor from chick brain. Biochemistry 25, 2082-2093.
274. Whiting, P. and Lindstrom, J. (1986b) Pharmacological properties of immuno-isolated neuronal nicotinic receptors. J. Neurosci. 6, 3061-3069.
275. Whiting, P. J., Liu, R., Morley, B. J. and Lindstrom, J. M. (1987a) Structurally different neuronal nicotinic acetylcholine receptor subtypes purified and characterized using monoclonal antibodies. J. Neurosci. 7, 4005-4016.
276. Whiting, P., Esch, F., Shimasaki, S. and Lindstrom, J. (1987b) Neuronal nicotinic acetylcholine receptor β-subunit is coded for by the cDNA clone α4. FEBS Lett. 219, 459-463.
277. Whiting, P., Schoepfer, R., Lindstrom, J. and Priestly, T. (1991) Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol. Pharmacol. 40, 463-472.
278. Wilkie, G. I., Hutson, P. H., Whiting, P. and Wonnacott, S. (1993) Hippocampal nicotinic autoreceptors modulate acetylcholine release. Biochem. Soc. Trans. 21, 429-431.
279. Willoughby, J. J., Ninkina, N. N., Beech, M. M., Latchman, D. S. and Wood, J. N. (1993) Molecular cloning of a human neuronal nicotinic acetylcholine receptor β3-like subunit. Neurosci. Lett. 155, 136-139.
280. Wilson, H. L. and Sargent, P. B. (1995) Perisynaptic surface distribution of multiple classes of nicotinic acetylcholine receptors on neurons in the chicken ciliary ganglion. J. Neurosci. 15, 7778-7795.
281. Wong, E. T., Holstad, S. G., Mennerick, S. J., Hong, S. E., Zorumski, C. F. and Isenberg, K. E. (1995) Pharmacological and physiological properties of a putative ganglionic nicotinic receptor, α3β4, expressed in transfected eucaryotic cells. Mol. Brain Res. 28, 101-109.
282. Wonnacott, S. (1990) The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol. Sci. 11, 216-219.
283. Wonnacott, S., Drasdo, A., Sanderson, E. and Rowell, P. (1990a) Presynaptic nicotinic receptors and the modulation of transmitter release. In: Ciba Foundation Symposium 152: The Biology of Nicotine Dependence, pp. 87-101. Ed. J. Marsh. John Wiley and Sons: Chichester.
284. Wonnacott, S., Russel, M. A., Stolerman, I. P., Eds (1990b) Nicotine Psychopharmacology: Molecular Cellular and Behavioural Aspects. Oxford University Press: Oxford.
285. Wonnacott, S., Albuquerque, E. X. and Bertrand, D. (1993) Methyllcaconitine: a new probe that discriminates between nicotinic acetylcholine receptor subclasses. Methods Neurosci. 12, 263-275.
286. Wonnacott, S., Wilkie, G., Soliakov, L. and Whitaker, P. (1995) Presynaptic nicotinic autoreceptors and heteroreceptors in the CNS. In: Advances in Pharmacological Sciences. Effects of Nicotine on Biological Systems II, pp. 87-94. Eds P. B. S. Clarke, M. Quik, F. Adlkofer and K. Thurau. Birkhäuser Verlag: Basel.
287. Wonnacott, S. (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci. 20, 92-98.
288. Wood, S., Schertzer, M. and Yaremko, M. L. (1995) Identification of the human neuronal nicotinic cholinergic α2 receptor locus, (CHRNA2), within an 8p21 mapped locus, by sequence homology with rat DNA. Somatic Cell Mol. Genet, 21, 147-150.
289. Woolf, N. J. (1991) Cholinergic systems in mammalian brain and spinal cord. Progr. Neurobiol. 37, 475-524.
290. Xuareb, J. H., Perry, E. K., Candy, J. M., Bonham, J. R., Perry, R. H. and Marshall, E. (1990) Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. J. Neurol. Sci. 99, 185-197.
291. Yang, X., McDonoug, J., Fyodorv, D., Morris, M., Wang, F. and Deneris, E. S. (1994) Characterization of an acetylcholine receptor alpha 3 gene promoter and its activation by the POU domain factor SCIP/Tst-1. J. Biol. Chem. 269, 10252-10264.
292. Yang, X., Griswell, H. E. and Breese, J. R. (1996) Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid containing neurons. J. Pharmacol. Expl Ther. 27, 482-489.
293. Yu, D., Zhang, L., Eiselé, J.-L., Bertrand, D., Changeux, J.-P. and Weight, F. F. (1996) Ethanol inhibition of nicotinic acetylcholine type α7 receptors involves the amino-terminal domain of the receptor. Mol. Pharmacol. 50, 1010-1016.
294. Zhang, X., Stjernlof, P., Adem, A. and Nordberg, A. (1987) Anatoxin-a: a potent ligand for nicotinic cholinergic receptors in rat brain. Eur. J. Pharmacol. 135, 457-458.
295. Zhang, Z., Vijayaraghavan, S. and Berg, D. K. (1994) Neuronal acetylcholine receptors that bind α-bungarotoxin with high affinity function as ligand-gated ion channels. Neuron 12, 167-177.
296. Zhang, Z., Coggan, J. S. and Berg, D. K. (1996) Synaptic currents generated by neuronal acetylcholine receptors sensitive to α-bungarotoxin. Neuron 17, 1231-1240.
297. Zheng, J. Q., Felder, M., Connor, J. A. and Poo, M. M. (1994) Turning of nerve growth cones induced by neurotransmitters. Nature 368, 140-144.
298. Zoli, M., Le Novère, N., Hill, J. A. Jr and Changeux, J. P. (1995) Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J. Neurosci. 15, 1912-1939.